07/12/2018 17:53:26

ImmusanT Chief Scientific Officer Robert Anderson, Ph.D. to Participate as a Featured Speaker During the Antigen-Specific Immune Tolerance Europe Conference 2018

CAMBRIDGE, Mass., Dec. 07, 2018 (GLOBE NEWSWIRE) -- ImmusanT, Inc., a clinical stage company leveraging its Epitope-Specific Immuno-Therapy™ (ESIT™) platform to deliver first-in-class peptide-based immunomodulatory vaccine therapies to patients with autoimmune diseases, announced today that Robert (Bob) Anderson, Ph.D., will be among the featured speakers during the Antigen-Specific Immune Tolerance Europe Conference 2018 in London from Dec. 10-12, 2018.

“I am delighted to have been invited to participate as a featured speaker during this conference,” said Dr. Anderson. “We have made significant strides in the discovery and development of immune tolerizing therapeutics that have the potential to transform how we treat patients with autoimmune disorders. I look forward to sharing my insights with other experts in the field.” 

The conference is the first, European centric platform that brings together key decision makers to discuss the translation of groundbreaking science into novel therapies that address significant unmet needs in a variety of autoimmune disorders.

About ImmusanT, Inc.

At ImmusanT, we are developing a new class of therapeutic vaccines to change the lives of people living with autoimmune diseases. Our Epitope-Specific Immuno-Therapy™ (ESIT™) platform provides a precision medicine approach to restoring immune tolerance across a range of diseases, including celiac disease and type 1 diabetes. Our lead program, Nexvax2®, is in clinical development with the goal of protecting celiac disease patients against the debilitating effects of gluten. www.ImmusanT.com 

Media Contact:

Andrew Mielach

Account Supervisor

LifeSci Public Relations

(646) 876-5868

amielach@lifescipublicrelations.com  

 

immusanT_logo_031111.jpg

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Apr
I:SP500
  Hejsa.   Lige lidt læsestof til påsken.   Langsigtet konjunktur:   Overraskende stigning i de le..
28
17 Apr
VELO
  Den eneste TA-ekspert var for mig alpehue, og nogle ganske få andre. Langt de fleste, som udtaler ..
27
15 Apr
VELO
Solen skinner++Envarsus viser vejen med endnu engang rigtig gode data. https://www.ncbi.nlm.nih.gov..
23
13 Apr
TEVA
TheNote: Stigendende priser: Hvis man kigge på Walmarts seneste regnskab kan man se at deres omsætni..
22
18 Apr
 
Jeg har modtaget flg. fra Delfin : "Nå, så er jeg blokeret på EI. Hvorfor ved jeg ikke. Jeg har ikke..
21
17 Apr
 
EI hvorfor har I slettet mit indlæg 414414 og hele debatten om hvad en moderater bør blande sig i ? ..
21
13 Apr
NOVO-B
TheNote. Jeg er imponeret over din seriøsitet som trådstarter - men dybt overrasket over din reaktio..
15
12 Apr
BEO SDB
Jeg tænker at EI med rette kunne hjælpe dig til en 2 ugers pause, det ville ihvertfald hjælpe os and..
13
17 Apr
TEVA
Den er også svær lige nu fordi mange korte og lange signaler krydser ind over hinanden lige nu. Men ..
11
15 Apr
VWS
Vestas i 600.. 😊 Det er en stor dag... Tillykke til de tålmodige og trofaste aktionærer.. Endelig ..
11

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
HQDA Acquires 51% of Palua Airline and Tourism Companies
2
Upper Street Marketing Inc. Announces Strategic Partnership in Canada
3
Bragar Eagel & Squire, P.C. is Investigating Lyft, Inc. (LYFT) on Behalf of Stockholders and Encourages LYFT Investors to Contact the Firm
4
American Indian College Fund Celebrates 30 Years of Service to Native Americans Pursuing Higher Education
5
Oak Valley Bancorp Reports 1st Quarter Results

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
19 April 2019 10:07:18
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190410.2 - EUROWEB3 - 2019-04-19 11:07:18 - 2019-04-19 10:07:18 - 1000 - Website: OKAY